Piramal Pharma Limited Announces Results for Q1FY26
Key Highlights for Q1FY26
Revenue from Operations stood at ₹ 1,934 crores vs ₹ 1,951 crores in Q1FY25. Excluding the impact of destocking in one of the large CDMO product, the YoY revenue growth was in early double-digit
EBITDA margin at 9% vs 11% in Q1FY25. Impact of inventory destocking, partly offset by improved profitability of the overseas facilities in the CDMO business
Net-Debt to EBITDA ratio at 2.6x
Best-in-Class Quality Track Record – Successfully closed USFDA inspection at Aurora facility (Canada) with zero observations. Continue to maintain our 'Zero OAIs' status since 2011
Sustainability Efforts Yielding Results – Assigned an ESG rating of '61' for FY2024 by NSE Sustainability Ratings and Analytics Limited
Nandini Piramal, Chairperson, Piramal Pharma Limited said, " Excluding the impact of destocking in one large on-patent commercial product, our CDMO business delivered mid-teen revenue growth during the quarter accompanied by improvement in EBITDA margin, especially at our overseas sites. Growth in our CHG business is also expected to pick up for the remaining part of the year given the timing of some of the institutional orders. Our consumer business delivered healthy growth, in-line with our expectations, driven by power brands and e-commerce sales.
Withstanding the near-term challenges, we believe we are on track to achieve our FY2030 aspirations of becoming a US$2bn revenue company with 25% EBITDA margin and high-teen ROCE."
Key Business Highlights for Q1 FY2026
Contract Development and Manufacturing Organization (CDMO):
- Mid-teens growth in base business i.e. excluding impact of destocking in one large on-patent commercial product. The growth was primarily led by the overseas facilities accompanied by YoY improvement in their profitability
- Nutrition Supplement and Generic API business also delivered good growth during the quarter
- Cost optimization through better procurement strategies and operational excellence initiatives
- Successfully closed USFDA inspection at Aurora (Canada) facility with zero observations. Aurora facility specializes in API development and manufacturing
- Broke ground for our capacity expansion project at Lexington (US), which specializes in sterile injectable drug products. This should lend impetus to our integrated ADC development and manufacturing program over the medium to long term
- Biotech Funding - Incomplete and inconsistent recovery in funding for emerging biopharma companies leading to prolonged decision making by the customers and slower growth in early-stage development projects
Complex Hospital Generics (CHG):
- Inhalation Anesthesia (IA) - Slower growth in Q1FY26 due to phasing of institutional orders. Expect growth to pick up in the remaining part of the financial year
o Slower growth in the key market of US, partly offset by encouraging growth in some ex-US markets
o Received USFDA approval for Digwal (India) facility as Sevoflurane API and finished product manufacturing site for both human and veterinary use
- Intrathecal Therapy – Lower sales in Q1FY26 due to timing of shipment at the end of June. Growth expected to recover in Q2FY26
- Injectable Anesthesia and Pain Management – Initiatives to resolve supply constraints on track. Expect the benefits to accrue from FY2027
- Differentiated and Specialty Products - Neoatricon® 1 launched in select EU markets in Q1FY26. Expect to launch in more markets in Q2FY26
Piramal Consumer Healthcare (PCH):
- Power Brands continue to grow strong with 18% YoY growth during Q1FY26. Power Brands contributed to 49% of total PCH sales
o Growth was primarily driven by Little's, i-range, and CIR
o Healthy recovery in growth of i-range from impact of regulator induced price control
- New Product Launches - Added 7 new products in Q1FY26
- Investments in Media and Promotions – 13% of PCH sales in Q1FY26
- E-commerce sales grew at 41% YoY in Q1FY26, contributing 23% to PCH sales
1.Exceptional items include, one time insolvency proceeds received from a claim filed against a third-party supplier of our complex hospital generics business, with the NCLT in November 2023
Q1FY26 Earnings Conference Call
Piramal Pharma Limited will be hosting a conference call for investors / analysts on 29 th July 2025 from 9:30 AM to 10:15 AM (IST) to discuss its Q1FY26 Results.
The dial-in details for the call are as under:
About Piramal Pharma Limited:
Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 1 global development and manufacturing facilities and a global distribution network in over 100 countries. PPL includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business; and Piramal Consumer Healthcare business, selling over-the-counter consumer and wellness products. In addition, one of PPL's associate companies, Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, has emerged as one of the market leaders in the ophthalmology therapy area in the Indian pharma market. Further, PPL has a strategic minority investment in Yapan Bio Private Limited, that operates in the biologics / bio-therapeutics and vaccine segments.
SOURCE Piramal Pharma Ltd
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
28 minutes ago
- Cision Canada
EV PROJECTS LIMITED ANNOUNCES INVESTMENT IN ORDINARY SHARES OF SEDIBELO RESOURCES LIMITED
ST. HELIER, Jersey, Aug. 21, 2025 /CNW/ - EV Projects Limited (" EVP") announced today that on August 18, 2025, it acquired 1,547,987,616 ordinary shares (the " Acquired Shares") in the capital of Sedibelo Resources Limited (the " Corporation") for aggregate consideration of US$5 million, or US$0.00323 per ordinary share, pursuant to a private placement (the " Private Placement"). The Acquired Shares represent approximately 17.8% of the Corporation's total issued and outstanding ordinary shares. In addition, EVP also acquired 1,547,987,616 options to purchase ordinary shares (the " Acquired Options") of the Corporation in connection with its subscription for the Acquired Shares. Each Acquired Option is exercisable to acquire one ordinary share (a " Option Share") at a price of US$0.00323 per Option Share for a period of three years from the date of issue. On a partially diluted basis, assuming all outstanding options of the Corporation are exercised in full except for the Acquired Options, EVP would hold 1,547,987,616 ordinary shares, representing approximately 9.5% of the total issued and outstanding shares. Alternatively, if only the Acquired Options are exercised in full while no other shareholders exercise their options, EVP's holdings would increase to 3,095,975,232 ordinary shares, representing approximately 30.2% of the issued and outstanding shares. If no shareholders, including EVP, exercise their options, EVP's ownership would remain at 17.8%. EVP acquired the Acquired Shares and Acquired Options for investment purposes. EVP may, from time to time, acquire additional securities, dispose of some or all of the currently held or additional securities or may continue to hold the securities of the Corporation. An early warning report relating to these transactions will be filed on the System for Electronic Document Analysis and Review + under the Corporation's profile and can be viewed at
CTV News
28 minutes ago
- CTV News
Google to provide Gemini AI tools to U.S. government
The Google DeepMind website on a laptop computer arranged in New York, US, on Friday, Dec. 8, 2023. Alphabet's Google said Gemini is its largest, most capable and flexible AI model to date, replacing PaLM 2, released in May. Photographer: Gabby Jones/Bloomberg Google will provide its Gemini artificial intelligence tools to U.S. federal agencies practically free, the government announced Thursday. A suite of AI and cloud computing services called 'Gemini for Government' from Google is intended to speed the adoption of the technology across the U.S. government, the General Services Administration (GSA) said in a joint statement. 'Gemini for Government gives federal agencies access to our full stack approach to AI innovation,' added Google chief executive Sundar Pichai. 'So they can deliver on their important missions.' AI tools being provided include generation of video, images, or ideas as well as digital 'agents' capable of independently tending to complex tasks. U.S. agencies will pay a scant fee of less than a dollar for the AI tools, building on a previous agreement that saw Google Workspace software provided to the government at a major price discount, according to the GSA. 'Federal agencies can now significantly transform their operations by using the tools in Gemini for Government,' said GSA acting administrator Michael Rigas. The deal comes just weeks after Google rival OpenAI said it was letting the U.S. government use a version of ChatGPT designed for businesses for a year for just $1. 'By giving government employees access to powerful, secure AI tools, we can help them solve problems for more people, faster,' OpenAI said in a blog post announcing the alliance. Earlier this year, the U.S. Department of Defense awarded OpenAI a US$200 million contract to put generative AI to work for the military. OpenAI planned to show how cutting-edge AI can improve administrative operations, such as how service members get health care, and also has cyber defense applications, the startup said in a post.
Globe and Mail
an hour ago
- Globe and Mail
Verizon vs. AT&T: Which Telecom Stock Has More Upside Potential?
Verizon Communications Inc. VZ and AT&T, Inc. T are prominent players in the telecommunications industry. As one of the leading wireless carriers in the United States, Verizon delivers communication services to a vast customer base across the public sector, small, medium businesses and global enterprises as well. AT&T is also one of the larger telecom companies in North America, boasts a large user base and offers a wide array of communication and business solutions that include wireless, local exchange, long-distance, data/broadband and Internet, video, managed networking, wholesale and cloud-based services. Per Grand View Research, the U.S. telecom services market is expected to witness a 6.6% compound annual growth rate between 2024 and 2030. The U.S. Fiber to the home market size is projected to grow from $10.7 billion to $21.5 billion in 2030 with a CAGR of 12.7%. Let us analyze in depth the competitive strengths and weaknesses of the companies to understand which of AT&T or Verizon is in a better position to maximize gains from these emerging market trends. The Case for AT&T 5G deployment and adoption in the United States is driven by a multitude of forces. Spectrum availability and regulatory support were the initial drivers of 5G growth, but currently growing usage of several high-end applications across several sectors has become a key driver. 5G networks enable high-speed internet with low latency. Advanced use cases such as AI applications, IoT devices and cellular vehicle-to-everything (C-V2X) applications require a network connectivity. AT&T is focusing on network infrastructure modernization to gain from this 5G boom. In order to have a seamless transition among Wi-Fi, Long-Term Evolution (LTE) and 5G services, AT&T intends to deploy a standards-based nationwide mobile 5G network. Its 5G service entails the utilization of millimeter wave spectrum for deployment in dense pockets, while in suburban and rural areas, it intends to deploy 5G on mid- and low-band spectrum holdings. The company's also aggressively expanding its fiber infrastructure across the country. Its fiber broadband network has reached 30 million consumer and business locations across the United States. The company is also collaborating with Ericsson to deploy a commercial-scale open radio access network (Open RAN) across the country to help build a more robust ecosystem of network infrastructure providers and suppliers. The Open RAN architecture facilitates healthy competition among vendors for the supply of essential components and reduces dependence on a single manufacturer. It is likely to offer more flexibility, lower costs and help develop novel ideas to monetize the network. AT&T aims to deploy Open RAN for 70% of its wireless network traffic across open-capable platforms by late 2026. AT&T is also collaborating with Microsoft to move its 5G mobile network to the latter's cloud. The process will start with AT&T's 5G core, which is the 5G network's main software that connects mobile users with the Internet. The move will enable AT&T to enhance productivity and deliver large-scale network services to meet customers' needs. The company has extended its long-standing business relationship with Google Cloud to offer end-to-end solutions for improved customer experiences. However, the company's margin is affected by intensifying competition in the 5G and Fiber Broadband market. The company faces stiff competition from other industry leaders such as T-Mobile, US, Inc. TMUS and Verizon. T-Mobile has a strong position in the U.S. 5G market. The company's 5G network covers 98% of Americans, or 330 million people in the country. About 55% of postpaid customers are using a 5G phone, and 5G devices account for more than half of the total network traffic. The company is steadily expanding into underserved rural regions, which could pose a challenge to AT&T's 5G initiatives. The Case for Verizon Verizon is witnessing significant 5G adoption and fixed wireless broadband momentum. The telecom giant plans to accelerate the availability of its 5G Ultra-Wideband network across the country. Its 5G network hinges on three fundamental drivers to deliver the full potential of next-generation wireless technology. These include massive spectrum holdings, particularly in the millimeter-wave bands for faster data transfer, end-to-end deep fiber resources and the ability to deploy a large number of small cells. The company's C-Band spectrum offers greater coverage for 5G networks and greater speeds than on low-band spectrum, and paves the way to provide differentiated service of 5G Ultra-Wideband to millions of customers. Verizon's customer segmentation strategy, which categorizes different client groups, helps it deliver tailored solutions to different sectors. Such personalized offerings help in client retention and drive average revenue per account growth. Its three-year price lock guarantee will ensure the core monthly plan price for calling, data and texting will not change in the next three-year period, excluding taxes, fees and perks. The company also introduced cutting-edge AI-native features to boost customer service. Such initiatives are driving customer engagement. However, the company operates in a highly competitive U.S. wireless market. High market saturation has made the customer base highly price sensitive, leaving little room for price adjustments. In a bid to expand its customer base, Verizon is spending heavily on promotion and is also offering lucrative discounts, which are weighing on company recorded high capital expenditures in order to support the launch and continued build-out of its 5G Ultra Wideband network, deployment of significant fiber assets across the country and upgrade to Intelligent Edge Network architecture. It remains unclear if and when a reasonable return can be achieved from such investments. To counter these issues, the company has been steadily expanding its portfolio offerings to develop advanced use cases. It has introduced Edge Transportation Exchange, a state-of-the-art mobile-network vehicle-to-everything (V2X) communication platform for connected vehicles. The cutting-edge solution incorporates Verizon's industry-leading 5G, LTE mobile networks, and Verizon 5G Edge mobile edge compute to enable vehicles to communicate and share important data with each other. Such initiatives open up new streams for revenue generation and bode well for long-term growth. How Do Zacks Estimates Compare for VZ & T? The Zacks Consensus Estimate for Verizon's 2025 sales and EPS implies year-over-year growth of 2.51% and 2.4%, respectively. The EPS estimates have moved northward over the past 60 days. The Zacks Consensus Estimate for AT&T's 2025 sales indicates growth of 2.16% year over year, while EPS is projected to decline 9.29%. The EPS estimates have been trending upward over the past 60 days. Image Source: Zacks Investment Research Price Performance & Valuation of VZ & T Over the past year, Verizon has gained 9.6% compared with the industry 's growth of 27%. T has gained 50.8% over the same period. Image Source: Zacks Investment Research Verizon looks more attractive than AT&T from a valuation standpoint. Going by the price/earnings ratio, Verizon's shares currently trade at 9.28 forward earnings, lower than 13.41 for AT&T. VZ or T: Which is a Better Pick? Verizon and AT&T carry a Zacks Rank #3 (Hold) each. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Both companies are swiftly strengthening their 5G infrastructure and are also aggressively venturing into the fiber broadband market. However, with a customer-centric business model, AT&T is witnessing healthy momentum in its postpaid wireless business with a lower churn rate and increased adoption of higher-tier unlimited plans. Strategic collaboration with various industry leaders to improve customer experience is a positive factor. Its extensive network modernization efforts will boost prospects in the long run. With better price performance and upward estimate revision, AT&T appears to be a better investment option at the moment. See our %%CTA_TEXT%% report – free today! 7 Best Stocks for the Next 30 Days Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AT&T Inc. (T): Free Stock Analysis Report Verizon Communications Inc. (VZ): Free Stock Analysis Report T-Mobile US, Inc. (TMUS): Free Stock Analysis Report
